Literature DB >> 16353944

Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniques.

Joshua T Ayers1, Aaron Clauset, Jeffrey D Schmitt, Linda P Dwoskin, Peter A Crooks.   

Abstract

The neuronal nicotinic acetylcholine receptor (nAChR) has been a target for drug development studies for over a decade. A series of mono- and bis-quaternary ammonium salts, known to be antagonists at nAChRs, were separated into 3 structural classes and evaluated using both self-organizing map (SOM) and genetic functional approximation (GFA) algorithm models. Descriptors from these compounds were used to create several nonlinear quantitative structure-activity relationships (QSARs). The SOM methodology was effective in appropriately grouping these compounds with diverse structures and activities. The GFA models were also able to predict the activities of these molecules. Charge distribution and the hydrophobic free energies were found to be important indicators of bioactivity for this particular class of molecules. These QSAR approaches may be a useful to screen and select in silico new drug candidates from larger compound libraries to be further evaluated in in vitro biological assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353944      PMCID: PMC2751270          DOI: 10.1208/aapsj070368

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  25 in total

1.  An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by.

Authors:  J E Tønder; P H Olesen; J B Hansen; M Begtrup; I Pettersson
Journal:  J Comput Aided Mol Des       Date:  2001-03       Impact factor: 3.686

Review 2.  Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.

Authors:  J E Tønder; P H Olesen
Journal:  Curr Med Chem       Date:  2001-05       Impact factor: 4.530

Review 3.  Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.

Authors:  J D Schmitt
Journal:  Curr Med Chem       Date:  2000-08       Impact factor: 4.530

4.  Quantitative structure-activity relationship studies of progesterone receptor binding steroids.

Authors:  S S So; S P van Helden; V J van Geerestein; M Karplus
Journal:  J Chem Inf Comput Sci       Date:  2000 May-Jun

Review 5.  Neuronal nicotinic acetylcholine receptors as novel drug targets.

Authors:  G K Lloyd; M Williams
Journal:  J Pharmacol Exp Ther       Date:  2000-02       Impact factor: 4.030

6.  Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore.

Authors:  O Nicolotti; M Pellegrini-Calace; A Carrieri; C Altomare; N B Centeno; F Sanz; A Carotti
Journal:  J Comput Aided Mol Des       Date:  2001-09       Impact factor: 3.686

Review 7.  Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery.

Authors:  L P Dwoskin; P A Crooks
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

8.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

9.  Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.

Authors:  R Xu; L P Dwoskin; V P Grinevich; G Deaciuc; P A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2001-05-07       Impact factor: 2.823

10.  Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models.

Authors:  V M Gokhale; V M Kulkarni
Journal:  Bioorg Med Chem       Date:  2000-10       Impact factor: 3.641

View more
  2 in total

1.  QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

Authors:  Fang Zheng; Matthew J McConnell; Chang-Guo Zhan; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2009-05-08       Impact factor: 3.641

2.  Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.

Authors:  Linda P Dwoskin; Marharyta Pivavarchyk; B Matthew Joyce; Nichole M Neugebauer; Guangrong Zheng; Zhenfa Zhang; Michael T Bardo; Peter A Crooks
Journal:  Nebr Symp Motiv       Date:  2009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.